The implementation of QIs in the pursuit of improving patient outcomes in oncological care has become a primary goal for many countries. The purpose of this cross-sectional review is to present the experiences of several countries that have implemented different strategies in using QIs to assess the quality of cancer care. Countries such as the United States, the United Kingdom, Canada, the Netherlands, Australia, and Israel have been pioneers in integrating QIs into their healthcare systems, which has led to significant improvements in the delivery of care. These indicators help assess adherence to clinical guidelines, timeliness of treatment, safety of practices, and overall patient survival. Data from these countries show that the use of QIs correlates with improved five-year survival rates, earlier diagnosis, better adherence to evidence-based treatment protocols, and increased patient satisfaction. For example, in the Netherlands and Germany, the introduction of quality cancer care programs has led to improved surgical outcomes and overall survival for patients with colorectal cancer. The United Kingdom and Denmark have reported improvements in waiting times for diagnosis and treatment, and in Israel, screening rates for breast and colorectal cancer increased after the introduction of QIs for monitoring these conditions. The current review highlights the fact that countries with robust reporting systems and national cancer registries with high levels of data completeness, such as Denmark, Sweden, and Norway, were able to effectively monitor outcomes and adjust clinical practices accordingly. The findings suggest that implementing QIs in cancer care not only improves clinical outcomes but also promotes accountability and stimulates improved healthcare, ensuring better long-term patient care. This study highlights the value of adopting QIs as a global standard for assessing cancer care.
在肿瘤治疗领域，实施质量指标以改善患者预后已成为许多国家的首要目标。本横断面综述旨在呈现多个国家运用不同策略实施质量指标评估癌症治疗质量的经验。美国、英国、加拿大、荷兰、澳大利亚和以色列等国率先将质量指标纳入医疗体系，显著提升了医疗服务水平。这些指标有助于评估临床指南依从性、治疗及时性、操作安全性及患者总体生存率。相关数据显示，质量指标的应用与五年生存率提升、早期诊断率提高、循证治疗方案依从性增强及患者满意度上升具有显著相关性。例如在荷兰和德国，癌症治疗质量项目的实施使结直肠癌患者手术效果和总体生存率得到改善；英国和丹麦在诊断与治疗等待时间方面取得进展；以色列在引入乳腺癌和结直肠癌监测质量指标后，相关筛查率显著提升。本综述特别指出，丹麦、瑞典、挪威等拥有健全报告体系及高数据完整度国家癌症登记系统的国家，能够有效监测治疗结果并相应调整临床实践。研究结果表明，在癌症治疗中实施质量指标不仅能改善临床结局，还能强化医疗问责机制，推动医疗质量持续改进，从而保障患者获得更优质的长期照护。本研究强调了将质量指标作为全球癌症治疗评估标准的重要价值。
肿瘤(癌症)患者之家